Axonics, Inc. Net Change in Cash
Axonics, Inc. reported Net Change in Cash of $144.01 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2024-11-07
- Axonics, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was $130.95M, a 10300.79% increase year-over-year.
- Axonics, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was $1.26M.
- Axonics, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was -$7.70M.
- Axonics, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-03-31 was -$110.22M.
- Axonics, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$121.32M, a 775.21% decline from fiscal 2022.
- Axonics, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was $17.97M.
- Axonics, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was -$20.30M, a 128.96% decline from fiscal 2020.
- Axonics, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was $70.10M, a 3.68% decline from fiscal 2019.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2024-09-30 | $144.01M 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | $69.72M 10-Q · filed 2024-08-01 | |||
| 2024-03-31 | $130.95M 10-Q · filed 2024-04-30 | |||
| 2023-12-31 | -$121.32M 10-K · filed 2024-02-29 | |||
| 2023-09-30 | -$91.52M 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | -$93.50M 10-Q · filed 2024-08-01 | |||
| 2023-03-31 | $1.26M 10-Q · filed 2024-04-30 | |||
| 2022-12-31 | $17.97M 10-K · filed 2024-02-29 | |||
| 2022-09-30 | $20.45M 10-Q · filed 2023-10-31 | |||
| 2022-06-30 | -$17.64M 10-Q · filed 2023-07-31 | |||
| 2022-03-31 | -$7.70M 10-Q · filed 2023-05-02 | |||
| 2021-12-31 | -$20.30M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | -$12.38M 10-Q · filed 2022-11-09 | |||
| 2021-06-30 | -$10.04M 10-Q · filed 2022-08-01 | |||
| 2021-03-31 | -$110.22M 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $70.10M 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $98.20M 10-Q · filed 2021-11-04 | |||
| 2020-06-30 | $116.60M 10-Q · filed 2021-08-05 | |||
| 2020-03-31 | -$11.26M 10-Q · filed 2021-05-07 | |||
| 2019-12-31 | $72.78M 10-K · filed 2022-03-01 | |||
| 2019-09-30 | -$22.07M 10-Q · filed 2020-11-04 | |||
| 2019-06-30 | -$15.63M 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | -$8.97M 10-Q · filed 2020-05-05 | |||
| 2018-12-31 | $73.91M 10-K · filed 2021-03-01 | |||
| 2018-09-30 | -$4.25M 10-Q · filed 2019-11-14 | |||
| 2018-06-30 | $331.00K 10-Q · filed 2019-08-05 | |||
| 2018-03-31 | $22.98M 10-Q · filed 2019-05-08 |